Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum

Ninomiya,Itasu; Nagai,Noboru; Oyama,Katsunobu; Hayashi,Hironori; Tajima,Hidehiro; Kitagawa,Hirohisa; Fushida,Sachio; Fujimura,Takashi; Ohta,Tetsuo

doi:10.3892/or.2012.1885

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum

Authors:
- Itasu Ninomiya
- Noboru Nagai
- Katsunobu Oyama
- Hironori Hayashi
- Hidehiro Tajima
- Hirohisa Kitagawa
- Sachio Fushida
- Takashi Fujimura
- Tetsuo Ohta
View Affiliations

Affiliations: Gastroenterologic Surgery, Department of Oncology, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Ishikawa 920-8641, Japan
Published online on: June 26, 2012 https://doi.org/10.3892/or.2012.1885
Pages: 777-784
Copyright: © Ninomiya et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We examined the effects of the preferential cyclooxygenase-2 (COX-2) inhibitor celecoxib on tumorigenesis, angiogenesis, apoptosis, vascular endothelial growth factor (VEGF) protein expression and metastasis in HT-29 human colorectal carcinoma cell xenografts in nude mouse rectum. COX-2 mRNA expression was examined in the xenograft and metastatic sites. The antitumor effect of celecoxib in the xenografts was evaluated by measuring the weight of the peri-ano-rectal tumor. The anti-metastatic effect of celecoxib was assessed by quantification of lymph node and lung metastases by amplification of a cancer-related human DNA by TaqMan PCR. The effects of celecoxib on angiogenesis, apoptosis, prostaglandin E2 (PGE2) production and VEGF protein expression in the xenografts were evaluated by means of microvessel density (MVD) counting, terminal deoxynucleotidyl transferase-mediated nick end labeling assay, quantitative enzyme-linked immunosorbent assay and western blotting, respectively. The rectal xenograft model showed lymph node and lung metastases with enhanced expression of COX-2 mRNA in each organ. Celecoxib inhibited rectal xenograft growth in a dose-dependent manner as follows: 150 ppm, 33.0% (p=0.000220); 750 ppm, 46.4% (p=0.0000292); 1500 ppm, 63.4% (p=0.0000109). Celecoxib inhibited lymph node metastasis in a dose-dependent manner as follows: 150 ppm, 86.7% (p=0.0263); 750 ppm, 90.3% (p=0.00638); 1500 ppm, 96.0% (p=0.000894). Celecoxib also inhibited lung metastasis as follows: 750 ppm, 53.3% (p=0.0107); 1500 ppm, 78.3% (p=0.00022). Celecoxib (1500 ppm) significantly inhibited PGE2 production by 68.4% (p=0.000157) and MVD counting by 48.2% (p=1.3x10-12) and induced apoptosis 2.5-fold (p=3.0x10-14) in the rectal xenograft. Celecoxib suppressed VEGF protein expression in the rectal xenograft. These studies demonstrate that celecoxib reduces the growth and metastatic potential of colorectal carcinoma in mice through COX-2 inhibition, anti-angiogenesis and apoptosis induction. The studies using HT-29 human colorectal carcinoma cell xenografts in nude mouse rectum also provide important information that supports that the COX-2 inhibitor celecoxib has a high potential for use as a clinical agent for inhibition of hematological and lymphatic metastases of colorectal cancer.

View Figures

View References

1	Smalley WE and DuBois RN: Colorectal cancer and non-steroidal anti-inflammatory drugs. Adv Pharmacol. 39:1–20. 1997. View Article : Google Scholar
2	Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
3	Yao M, Kargman S, Lam EC, et al: Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res. 63:586–592. 2003.PubMed/NCBI
4	Steinbach G, Lynch PM, Phillips RK, et al: The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 342:1946–1952. 2000. View Article : Google Scholar : PubMed/NCBI
5	Tomozawa S, Nagawa H, Tsuno N, et al: Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer. 81:1274–1279. 1999. View Article : Google Scholar : PubMed/NCBI
6	Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 231:232–235. 1971. View Article : Google Scholar : PubMed/NCBI
7	Wolfe MM, Lichtenstein DR and Singh G: Gastrointestinal toxicity of non-steroidal antiinflammatory drugs. N Engl J Med. 340:1888–1899. 1999. View Article : Google Scholar
8	Masferrer JL, Seibert K, Zweifel B and Needleman P: Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA. 89:3917–3921. 1992. View Article : Google Scholar : PubMed/NCBI
9	Kujubu DA, Fletcher BS, Varnum BC, Lim RW and Herschman HR: TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 266:12866–12872. 1991.
10	Kargman SL, O’Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:2556–2559. 1995.PubMed/NCBI
11	Oshima M, Dinchuk JE, Kargman SL, et al: Suppression of intestinal polyposis in Apc^Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:803–809. 1996.
12	Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 94:3336–3340. 1997. View Article : Google Scholar : PubMed/NCBI
13	Masferrer JL, Leahy KM, Koki AT, et al: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 60:1306–1311. 2000.PubMed/NCBI
14	Penning TD, Talley JJ, Bertenshaw SR, et al: Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methyl-phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). J Med Chem. 40:1347–1365. 1997.PubMed/NCBI
15	Silverstein FE, Faich G, Goldstein JL, et al: Gastrointestinal toxicity with celecoxib vs. non-steroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA. 284:1247–1255. 2000. View Article : Google Scholar
16	Chen WS, Wei SJ, Liu JM, Hsiao M, Kou-Lin J and Yang WK: Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. Int J Cancer. 91:894–899. 2001. View Article : Google Scholar : PubMed/NCBI
17	Kakiuchi Y, Tsuji S, Tsujii M, et al: Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res. 62:1567–1572. 2002.PubMed/NCBI
18	Ninomiya I, Terada I, Yoshizumi T, et al: Anti-metastatic effect of capecitabine on human colon cancer xenografts in nude mouse rectum. Int J Cancer. 112:135–142. 2004. View Article : Google Scholar : PubMed/NCBI
19	Blin N and Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:2303–2308. 1976. View Article : Google Scholar : PubMed/NCBI
20	Nagatsuka I, Yamada N, Shimizu S, et al: Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer. Int J Cancer. 100:515–519. 2002. View Article : Google Scholar : PubMed/NCBI
21	Yoshinaka R, Shibata MA, Morimoto J, Tanigawa N and Otsuki Y: COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer. Anticancer Res. 26:4245–4254. 2006.PubMed/NCBI
22	Evans DM and Sloan Stakleff KD: Control of pulmonary metastases of rat mammary cancer by inhibition of uPA and COX-2, singly and in combination. Clin Exp Metastasis. 21:339–346. 2004. View Article : Google Scholar : PubMed/NCBI
23	Zhang S, Lawson KA, Simmons-Menchaca M, Sun L, Sanders BG and Kline K: Vitamin E analog α-TEA and celecoxib alone and together reduce human MDA-MB-435-FL-GFP breast cancer burden and metastasis in nude mice. Breast Cancer Res Treat. 87:111–121. 2004.
24	Endo Y, Sasaki T, Harada F and Noguchi M: Specific detection of metastasized human tumor cells in embryonic chicks by the polymerase chain reaction. Jpn J Cancer Res. 81:723–726. 1990. View Article : Google Scholar
25	Williams CS, Tsujii M, Reese J, Dey SK and DuBois RN: Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest. 105:1589–1594. 2000. View Article : Google Scholar : PubMed/NCBI
26	Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT and Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 62:625–631. 2002.PubMed/NCBI
27	Zweifel BS, Davis TW, Ornberg RL and Masferrer JL: Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Cancer Res. 62:6706–6711. 2002.PubMed/NCBI
28	Wei D, Wang L, He Y, Xiong HQ, Abbruzzese JL and Xie K: Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Res. 64:2030–2038. 2004. View Article : Google Scholar
29	Honn KV, Bockman RS and Marnett LJ: Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins. 21:833–864. 1981. View Article : Google Scholar : PubMed/NCBI
30	Rochels R: Pathobiochemical aspects of corneal neovascularization. Fortschr Med. 102:101–102. 1984.(In German).
31	Liu H, Yang Y, Xiao J, et al: Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C. Anat Rec. 292:1577–1583. 2009. View Article : Google Scholar : PubMed/NCBI
32	Backhus LM, Sievers E, Lin GY, et al: Perioperative cyclooxygenase 2 inhibition to reduce tumor cell adhesion and metastatic potential of circulating tumor cells in non-small cell lung cancer. J Thorac Cardiovasc Surg. 132:297–303. 2006. View Article : Google Scholar : PubMed/NCBI
33	Roh JL, Sung MW, Park SW, Heo DS, Lee DW and Kim KH: Celecoxib can prevent tumor growth and distant metastasis in postoperative setting. Cancer Res. 64:3230–3235. 2004. View Article : Google Scholar : PubMed/NCBI
34	Farooqui M, Li Y, Rogers T, et al: COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer. 97:1523–1531. 2007. View Article : Google Scholar